Physician profile
Gerald E Keightley
NPI 1447256482
$224.06
in general payments reported to CMS, 2019-2025
8 companies · $34.67 in 2025
The $34.67 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.34 · 2021: $56.10 · 2022: $82.00 · 2024: $33.95 · 2025: $34.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $82.00 | 2022 | |
| Glaxosmithkline, LLC. | $35.60 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $31.45 | 2019-2024 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $21.08 | 2025 | Jynarque |
| Welch Allyn | $20.50 | 2021 | |
| Fresenius USA Marketing, INC. | $19.84 | 2024 | Velphoro |
| Scpharmaceuticals INC. | $13.59 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Keightley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.